Peptides DB
Research-centric peptide and protocol reference hub
Study 26 of 47NAD+ (Nicotinamide Adenine Dinucleotide) literatureSynthetic and systems biotechnology · In vitro2026

Evolution of alcohol oxidase for improved methanol bioconversion and formaldehyde tolerance.

Directed evolution of GtAOX_M3 significantly enhances methanol bioconversion efficiency, offering potential industrial applications.

Read at Synthetic and systems biotechnologyAdd to compare

Where it sits

this study against the rest of the nad+ (nicotinamide adenine dinucleotide) corpus
17
Preclinical · this one
23
Observational
1
Open-label
1
Randomised
5
Reviews

Summary and findings

The study reports on the directed evolution of an alcohol oxidase from Gloeophyllum trabeum, resulting in a variant with improved catalytic efficiency and formaldehyde tolerance. The optimized enzyme, GtAOX_M3, shows a sixfold increase in catalytic efficiency and enhanced performance in methanol bioconversion. It facilitates the conversion of methanol to dihydroxyacetone and ethylene glycol in multienzyme systems.

How much of this paper we could read: full text read (0.80). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Sixfold increase in catalytic efficiency (7.7 s^-1 mM^-1).2026

Abstract

The authors’ words, as Synthetic and systems biotechnology supplied them

Methanol oxidation by alcohol oxidases (AOXs) is a key bottleneck in one-carbon (C1) bioconversion due to limited catalytic efficiency and poor formaldehyde tolerance. Here, we report the directed evolution of an alcohol oxidase from Gloeophyllum trabeum, yielding an optimized variant, GtAOXM3. The engineered enzyme exhibits a sixfold increase in catalytic efficiency (7.7 s-1 mM-1), together with enhanced formaldehyde tolerance, thermostability, and high methanol specificity. Molecular dynamics simulations suggest that increased global rigidity and cooperative residue dynamics contribute to the improved performance. When incorporated in multienzyme cascade systems, GtAOXM3 enables efficient conversion of methanol to the value-added chemicals dihydroxyacetone (34.5 mM) and ethylene glycol (23.3 mM). This work establishes GtAOXM3 as an efficient and cost-effective biocatalyst for methanol-based C1 biotransformation.

Background

This study addresses the challenge of improving methanol oxidation in one-carbon bioconversion processes, which is hindered by the limited catalytic efficiency and formaldehyde tolerance of alcohol oxidases. Previous efforts have focused on enzyme engineering to enhance these properties, aiming to improve the bioconversion of methanol into valuable chemicals. The research is significant as it could lead to more efficient and cost-effective biocatalysts for industrial applications.

Methods

The study employed directed evolution techniques to optimize an alcohol oxidase from Gloeophyllum trabeum. The engineered enzyme, named GtAOX_M3, was evaluated for catalytic efficiency, formaldehyde tolerance, thermostability, and methanol specificity. Molecular dynamics simulations were used to analyze the structural changes contributing to the enzyme's performance. The enzyme's efficacy was tested in multienzyme cascade systems for methanol conversion.

Results

The primary finding was a sixfold increase in catalytic efficiency (7.7 s^-1 mM^-1) of the engineered enzyme GtAOX_M3. The enzyme also demonstrated enhanced formaldehyde tolerance, improved thermostability, and high specificity for methanol. In multienzyme systems, GtAOX_M3 enabled the conversion of methanol to dihydroxyacetone at 34.5 mM and ethylene glycol at 23.3 mM.

Interpretation

The study demonstrates significant improvements in the catalytic efficiency and stability of alcohol oxidase through directed evolution, which could have important implications for industrial methanol bioconversion processes. While the results are promising, they are based on in vitro experiments and require further validation in real-world applications. The findings align with previous research on enzyme optimization but offer enhanced performance metrics.

Key findings

  • Sixfold increase in catalytic efficiency (7.7 s^-1 mM^-1).
  • Enhanced formaldehyde tolerance and thermostability.
  • High methanol specificity.
  • Dihydroxyacetone production at 34.5 mM.
  • Ethylene glycol production at 23.3 mM.

Limitations

  • No in vivo or clinical data.
  • Results based on in vitro enzyme assays.
  • Limited to enzyme engineering context.

Elsewhere in the NAD+ (Nicotinamide Adenine Dinucleotide) corpus

CBioactive vitamin E-NAD<sup>+</sup> conjugate nanoparticles for osteoarthritis management via simultaneous suppression of inflammation and oxidative stress.Biomaterials · 2026 · Not reported in abstract.AnimalBNAD metabolism mediates a sex-specific protection against early life infectionsbiorxiv-preprint · 2026 · Higher birth NAD levels in females were associated with reduced infection burdens during the first 3 years of life.HumanBControl-referenced bacterial bioluminescence reveals a two-axis salivary response phenotype in benign and malignant breast disease.Talanta · 2026 · n=200 · Not reported in abstract.HumanBGenetic modulation of NAD(P)H homeostasis reveals distinct redox-coupled metabolic vulnerabilities.Nature metabolism · 2026 · Not reported in abstract.HumanDA context-dependent framework for targeting NAD metabolism in cancer.Cell metabolism · 2026reviewBPart 1 of a 2-part, open-label clinical trial evaluating repeated nicotinamide riboside parenteral administration: 3 consecutive days of intramuscular and subcutaneous injectionsbiorxiv-preprint · 2026 · 9.97% average daily increase in NAD+ for 100 mg IM.Human